tranexamic acid has been researched along with Canine Diseases in 8 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the incidence of tranexamic acid (TXA)-induced nausea and vomiting after the prophylactic use of 2 antiemetics, ondansetron and maropitant, compared with saline." | 9.34 | Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis. ( Bettschart-Wolfensberger, R; Hartnack, S; Kantyka, ME; Kutter, APN; Meira, C, 2020) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug that is used for uncontrolled bleeding of various origin." | 5.48 | Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum. ( Jud Schefer, RS; Olgiati, L; Sigrist, N, 2018) |
| "A prospective observational study was performed in canine clinical medicine to evaluate the emetic action and adverse effects of tranexamic acid." | 5.46 | Safety and efficacy of intravenous administration for tranexamic acid-induced emesis in dogs with accidental ingestion of foreign substances. ( Kawarai-Shimamura, A; Nakamura, A; Ogawa, A; Orito, K, 2017) |
| "To evaluate the incidence of tranexamic acid (TXA)-induced nausea and vomiting after the prophylactic use of 2 antiemetics, ondansetron and maropitant, compared with saline." | 5.34 | Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis. ( Bettschart-Wolfensberger, R; Hartnack, S; Kantyka, ME; Kutter, APN; Meira, C, 2020) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug used for the prophylaxis and treatment of haemorrhage of various origin." | 1.72 | Effect of early administration of tranexamic acid on ongoing haemorrhage in dogs with non-surgically treated haemoabdomen. ( Jud Schefer, RS; Kluge, K; Kutter, APN; Langenegger, L; Sigrist, NE, 2022) |
| "Hypersalivation was the only adverse event reported in 3% (1/28) of cats." | 1.72 | Retrospective analysis of the use of tranexamic acid in critically ill dogs and cats (2018-2019): 266 dogs and 28 cats. ( Kelley, M; Sinnott-Stutzman, V; Whelan, M, 2022) |
| "He was presented in hemorrhagic shock, with an initial lactate of 10." | 1.48 | Hyperfibrinolysis diagnosed with rotational thromboelastometry and treated with tranexamic acid in a dog with acute traumatic coagulopathy. ( Muri, B; Schmierer, P; Schwarz, A; Sigrist, N, 2018) |
| "Tranexamic acid (TXA) is an antifibrinolytic drug that is used for uncontrolled bleeding of various origin." | 1.48 | Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum. ( Jud Schefer, RS; Olgiati, L; Sigrist, N, 2018) |
| "A prospective observational study was performed in canine clinical medicine to evaluate the emetic action and adverse effects of tranexamic acid." | 1.46 | Safety and efficacy of intravenous administration for tranexamic acid-induced emesis in dogs with accidental ingestion of foreign substances. ( Kawarai-Shimamura, A; Nakamura, A; Ogawa, A; Orito, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sigrist, NE | 1 |
| Langenegger, L | 1 |
| Jud Schefer, RS | 2 |
| Kluge, K | 1 |
| Kutter, APN | 2 |
| Kelley, M | 1 |
| Sinnott-Stutzman, V | 1 |
| Whelan, M | 1 |
| Choi, JY | 1 |
| Kim, JH | 1 |
| Han, HJ | 1 |
| Kantyka, ME | 1 |
| Meira, C | 1 |
| Bettschart-Wolfensberger, R | 1 |
| Hartnack, S | 1 |
| Langhorn, R | 1 |
| Poulsen, MK | 1 |
| Heidemann, PL | 1 |
| Bochsen, L | 1 |
| Ritz, C | 1 |
| Kristensen, AT | 1 |
| Nielsen, LN | 1 |
| Orito, K | 1 |
| Kawarai-Shimamura, A | 1 |
| Ogawa, A | 1 |
| Nakamura, A | 1 |
| Muri, B | 1 |
| Schmierer, P | 1 |
| Schwarz, A | 1 |
| Sigrist, N | 2 |
| Olgiati, L | 1 |
1 trial available for tranexamic acid and Canine Diseases
| Article | Year |
|---|---|
Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
Topics: Animals; Antiemetics; Antifibrinolytic Agents; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind | 2020 |
7 other studies available for tranexamic acid and Canine Diseases
| Article | Year |
|---|---|
Effect of early administration of tranexamic acid on ongoing haemorrhage in dogs with non-surgically treated haemoabdomen.
Topics: Animals; Antifibrinolytic Agents; Dog Diseases; Dogs; Hemoperitoneum; Retrospective Studies; Thrombe | 2022 |
Retrospective analysis of the use of tranexamic acid in critically ill dogs and cats (2018-2019): 266 dogs and 28 cats.
Topics: Animals; Antifibrinolytic Agents; Cat Diseases; Cats; Critical Illness; Dog Diseases; Dogs; Hemangio | 2022 |
Suspected anaphylactic shock associated with administration of tranexamic acid in a dog.
Topics: Anaphylaxis; Animals; Cystitis; Cystotomy; Dog Diseases; Dogs; Hematuria; Hemorrhage; Male; Tranexam | 2019 |
Diagnosis of primary hyperfibrinolysis and in vitro investigation of the inhibitory effects of tranexamic acid in a group of dogs with sarcomas - A pilot study.
Topics: Animals; Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Coagulation Tests; Case-Control | 2021 |
Safety and efficacy of intravenous administration for tranexamic acid-induced emesis in dogs with accidental ingestion of foreign substances.
Topics: Animals; DNA, Bacterial; Dog Diseases; Dogs; Female; Foreign Bodies; Injections, Intravenous; Male; | 2017 |
Hyperfibrinolysis diagnosed with rotational thromboelastometry and treated with tranexamic acid in a dog with acute traumatic coagulopathy.
Topics: Accidents, Traffic; Animals; Antifibrinolytic Agents; Blood Coagulation Disorders; Dog Diseases; Dog | 2018 |
Effect of tranexamic acid on intra- and postoperative haemorrhage in dogs with surgically treated hemoperitoneum.
Topics: Animals; Antifibrinolytic Agents; Blood Pressure; Dog Diseases; Dogs; Hemoperitoneum; Postoperative | 2018 |